Philip P. Boudreau

Executive Vice President, Finance and Chief Financial Officer (principal financial officer), Abbott Laboratories

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Philip P. Boudreau signed the annual report of Abbott Laboratories as Executive Vice President, Finance and Chief Financial Officer (principal financial officer); the report was filed on February 20, 2026, the most recent filing in the record that ties Philip P. Boudreau to the seat.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Abbott Laboratories (ABT) Pharmaceutical Preparations	Executive Vice President, Finance and Chief Financial Officer (principal financial officer)	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

February 20, 202610-K filed
Philip P. Boudreau signed the annual report of Abbott Laboratories on Form 10-K as Executive Vice President, Finance and Chief Financial Officer (principal financial officer), filed February 20, 2026.
/s/ PHILIP P. BOUDREAU Robert B. Ford Philip P. Boudreau Chairman of the Board and Chief Executive Officer, and Director of Abbott Laboratories (principal executive officer) Executive Vice President, Finance and Chief Financial Officer (principal financial officer)
[1] Annual report on Form 10-K by Abbott Laboratories, filed with the SEC on February 20, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Abbott Laboratories. U.S. Securities and Exchange Commission, EDGAR, filed February 20, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Philip P. Boudreau wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.